SCOPE continues to be a central location for industry colleagues to meet and exchange ideas around clinical development. We had a great time at the 2020 meeting catching up with friends, clients and colleagues, as well as co-moderating a roundtable on protocol design and chairing a main session on site selection with esteemed industry practitioners. It was a whirlwind of…
Artificial Intelligence
In the industry of clinical research, we are accustomed to working with conservative companies that make decisions slowly. Look at the adoption of EDC – over how many decades now? Understandable, at least to a point. I’ve been in my new role at Phesi for 2 weeks now, and I am witnessing a refreshing change. Artificial intelligence started to sneak…
As we head into Thanksgiving, we reflect upon all we have accomplished since January and our vision for 2020. At Phesi, we had quite a few firsts in 2019 and much to be thankful for, such as: Successfully launching our flagship product, ClinSite™ – a self-service, artificial intelligence (AI)-powered tool that enables biopharmaceutical companies to search for and select top-performing…